Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
Clinical trial NCT05094570 · RECRUITING
Trial details
- NCT number
- NCT05094570
- Sponsor
- University of Virginia
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2026-06-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.